AC
CRVO icon

Armistice Capital’s CervoMed CRVO Stock Holding History

Armistice Capital’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-402,000
Closed -$5.87M – 254
2024
Q3 		$5.87M Sell
402,000
-238,000
-37% -$3.69M 0.09% 114
2024
Q2 		$11M Sell
640,000
-94,363
-13% -$2.06M 0.14% 86
2024
Q1 		$17.1M Buy
+734,363
New +$9.8M 0.23% 76

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Armistice Capital's CRVO Position: Q4 2024 in Review

Armistice Capital sold out of CervoMed (CRVO) in Q4 2024, closing a stake of 402,000 shares — an estimated $5.87M sold.

Armistice Capital first reported a position in CRVO in Q1 2024 and held it in 3 quarters. The position peaked at $17.1M in Q1 2024. 49 funds tracked by Wall St. Rank hold CRVO as of Q4 2024.

  • Armistice Capital reported no remaining CervoMed position as of Q4 2024 after selling out during the quarter.
  • Armistice Capital sold 402,000 CervoMed shares in Q4 2024, an estimated $5.87M.
  • Armistice Capital first reported a position in CervoMed in Q1 2024 and held it in 3 quarters.
  • Armistice Capital's CervoMed position peaked at $17.1M in Q1 2024.
  • 49 funds tracked by Wall St. Rank held CervoMed as of Q4 2024.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.